Drugs / L9-NC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00492141 | Jun 2006 → May 2007 | Ewing sarcoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L9-NC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00492141 ↗ |
| Route | Inhaled | “L9-NC aerosol (an inhaled spray)” NCT00492141 ↗ |